You are here:Home-Chemical Inhibitors & Agonists-Wnt/Notch/Hedgehog-Notch-Z271-0326
Z271-0326

Chemical Structure : Z271-0326

CAS No.: 1243002-72-3

Z271-0326 (Z 271-0326)

Catalog No.: PC-20216Not For Human Use, Lab Use Only.

Z271-0326 is a first-in-class, potent and specifc inhibitor of NACK (Notch activation complex kinase) with SPR KD value of 0.89 uM, directly blocks NACK recruitment to the Notch ternary complex (NTC).

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
250 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    Z271-0326 is a first-in-class, potent and specifc inhibitor of NACK (Notch activation complex kinase) with SPR KD value of 0.89 uM, directly blocks NACK recruitment to the Notch ternary complex (NTC).
    Z271-0326 enhanced the NACK ATPase activity in a manner dependent on the ATP concentration.
    Z271-0326 displayed a dose-dependent reduction in colony formation in both OE19 (EC50=3.6 μM) and OE33 (EC50=3.14 μM) cell lines.
    Z271-0326 inhibited NACK, Notch1, and MAML1 binding to DNA-bound CSL (CBF-1/RBP-J, Su(H), Lag-1), whereas no effect was observed in CSL binding to DNA.
    Z271-0326 significantly inhibited the transcription of Notch target genes in both OE19 and OE33 cell lines, inhibited proliferation by causing cell-cycle arrest and apoptosis in esophageal adenocarcinoma.
    Z271-0326 (15 mg/kg, i.p.) showed in vivo efficacy in the inhibition of tumor progression in the OE19 xenograft model.

    Physicochemical Properties

    M.Wt 497.61
    Formula C25H31N5O4S
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20°C 12 Months; 4°C 6 Months
    In Solvent
    -80°C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    5-(1-((4-acetamidophenyl)sulfonyl)piperidin-4-yl)-N,N-diethylpyrazolo[1,5-a]pyridine-3-carboxamide

    References

    1. Diluvio G, et al. Mol Ther Oncolytics. 2023 Feb 22;28:307-320.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: